Expanding product offering by assessing novel technologies
A large medical device client, based in the United States, with capabilities in drug delivery medical devices, involved DelveInsight to assess the potential risks and benefits of a merger being evaluated to further the goal of becoming market leaders in the niche area of drug delivery through a novel technology (dissolvable microneedle technology) for drug delivery. The client wanted to include certain intellectual property in their portfolio through this deal, but was concerned about impact of the merger in their overall business strategy.